High-throughput strategies for monoclonal antibody screening: advances and challenges
Guardado en:
| Publicado en: | Journal of Biological Engineering vol. 19 (2025), p. 1 |
|---|---|
| Autor principal: | |
| Otros Autores: | , , , , |
| Publicado: |
Springer Nature B.V.
|
| Materias: | |
| Acceso en línea: | Citation/Abstract Full Text Full Text - PDF |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
MARC
| LEADER | 00000nab a2200000uu 4500 | ||
|---|---|---|---|
| 001 | 3201879018 | ||
| 003 | UK-CbPIL | ||
| 022 | |a 1754-1611 | ||
| 024 | 7 | |a 10.1186/s13036-025-00513-z |2 doi | |
| 035 | |a 3201879018 | ||
| 045 | 2 | |b d20250101 |b d20251231 | |
| 084 | |a 113324 |2 nlm | ||
| 100 | 1 | |a Xiao-Dong Wango-Ying Ma | |
| 245 | 1 | |a High-throughput strategies for monoclonal antibody screening: advances and challenges | |
| 260 | |b Springer Nature B.V. |c 2025 | ||
| 513 | |a Journal Article | ||
| 520 | 3 | |a Antibodies characterized by high affinity and specificity, developed through high-throughput screening and rapid preparation, are crucial to contemporary biomedical industry. Traditional antibody preparation via the hybridoma strategy faces challenges like low efficiency, long manufacturing cycles, batch variability and labor intensity. Advances in molecular biology and gene editing technologies offer revolutionary improvements in antibody production. New high-throughput technologies like antibody library display, single B cell antibody technologies, and single-cell sequencing have significantly cut costs and boosted the efficiency of antibody development. These innovations accelerate commercial applications of antibodies, meeting the biopharmaceutical industry's evolving demands. This review explores recent advancements in high-throughput development of antibody, highlighting their potential advantages over traditional methods and their promising future. | |
| 653 | |a Phages | ||
| 653 | |a Monoclonal antibodies | ||
| 653 | |a Genetic modification | ||
| 653 | |a Library technology | ||
| 653 | |a Molecular biology | ||
| 653 | |a High-throughput screening | ||
| 653 | |a Cloning | ||
| 653 | |a Genetic engineering | ||
| 653 | |a Drug development | ||
| 653 | |a Antigens | ||
| 653 | |a Automation | ||
| 653 | |a Yeast | ||
| 653 | |a Screening | ||
| 653 | |a Antibody libraries | ||
| 653 | |a Efficiency | ||
| 653 | |a Proteins | ||
| 653 | |a Environmental | ||
| 700 | 1 | |a Shi-Ying, Lai | |
| 700 | 1 | |a Xiang-Jing Cai | |
| 700 | 1 | |a Yan-Guang Cong | |
| 700 | 1 | |a Jun-Fa Xu | |
| 700 | 1 | |a Peng-Fei, Zhang | |
| 773 | 0 | |t Journal of Biological Engineering |g vol. 19 (2025), p. 1 | |
| 786 | 0 | |d ProQuest |t Health & Medical Collection | |
| 856 | 4 | 1 | |3 Citation/Abstract |u https://www.proquest.com/docview/3201879018/abstract/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch |
| 856 | 4 | 0 | |3 Full Text |u https://www.proquest.com/docview/3201879018/fulltext/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch |
| 856 | 4 | 0 | |3 Full Text - PDF |u https://www.proquest.com/docview/3201879018/fulltextPDF/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch |